ASCENSION SETON EDGAR B DAVIS — History
CCN 451371 | 3-year financial timeline | COVID resilience: 77/100
🛡️ Public data only — no PHI permitted on this instance.
$35M
Latest Revenue (FY2022)
+11.5%
Revenue CAGR (3yr)
5.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $28M | $34M | $35M | +4.8% | +11.5% |
| Operating Expenses | $29M | $30M | $33M | +9.7% | +7.8% |
| Operating Margin | -1.6% | 9.4% | 5.1% | -45.2% | +0.0% |
| Net Income | $-0M | $3M | $2M | -42.6% | +0.0% |
| Licensed Beds | 23 | 23 | 23 | +0.0% | +0.0% |
| Total Patient Days | 2,633 | 2,890 | 2,585 | -10.6% | -0.9% |
| Medicare Day % | 27% | 24% | 21% | -12.7% | -12.3% |
| Medicaid Day % | 0% | 1% | 0% | -68.7% | -19.5% |
COVID Impact & Recovery
Resilience Score: 77/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +24.4% ($28M → $35M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+11.5%
This Hospital
+7.6%
State Avg
Latest Margin
5.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $39M | 8.5% |
| FY2024 (proj) | $42M | 11.9% |
| FY2025 (proj) | $45M | 15.3% |